Establishment and External Validation of a Hypoxia-Derived Gene Signature for Robustly Predicting Prognosis and Therapeutic Responses in Glioblastoma Multiforme

OBJECTIVE: Hypoxia presents a salient feature investigated in most solid tumors that holds key roles in cancer progression, including glioblastoma multiforme (GBM). Here, we aimed to construct a hypoxia-derived gene signature for identifying the high-risk GBM patients to guide adjuvant therapy and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ke, Lu, Yang, Liu, Zhihong, Diao, Min, Yang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837434/
https://www.ncbi.nlm.nih.gov/pubmed/35155681
http://dx.doi.org/10.1155/2022/7858477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837434/
https://www.ncbi.nlm.nih.gov/pubmed/35155681
http://dx.doi.org/10.1155/2022/7858477

Ejemplares similares